Cystic Fibrosis - 2/8

Entry	Author	Date	Location
Gilead’s Lung Drug Ace, Bruce Montgomery, Hits Free Agent Market, Scopes Startup Ideas	Luke Timmerman	08/05/10	Seattle
Lucky 13: Xconomy Boston’s Top Stories of 2010 (So Far)	Gregory T. Huang	07/23/10	Boston
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News	Erin Kutz	07/09/10	Boston
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal	Ryan McBride	07/08/10	Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug	Ryan McBride	07/02/10	Boston
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News	Luke Timmerman	06/24/10	Seattle
Gilead CF Drug Passes Trial	Luke Timmerman	06/18/10	San Francisco
FoldRx Pharma Finds $29M, Plans to Seek Approval of First Drug in 2010	Ryan McBride	06/15/10	Boston
Sequenom Highlights Its Good News, Keeps Lid on Bad	Bruce V. Bigelow	03/15/10	San Diego
Bruce Montgomery Joins Zymo Board	Luke Timmerman	03/11/10	Seattle
Avila Sets Out to Take on Vertex, CombinatoRx Nails FDA Approval, Millipore Opts for Merck KGaA over Thermo Fisher, & More Boston-Area Life Sciences News	Erin Kutz	03/05/10	Boston
Prominent Flatley Family Launches Boston Nonprofit for Cystic Fibrosis Drug Research	Ryan McBride	03/03/10	Boston
Gilead Sciences Gets FDA Green Light To Sell Cystic Fibrosis Drug	Luke Timmerman	02/23/10	Seattle
Alnara Bags $35M B Round, Plans to Seek FDA Approval for Cystic Fibrosis Drug	Ryan McBride	01/28/10	Boston
Vertex’s Matt Emmens on His Journey From Security Guard to CEO	Luke Timmerman	01/27/10	Boston
Gilead Deepens Roots in Seattle, Seeks Long-Term Payoff From Lung Disease Research	Luke Timmerman	01/13/10	Seattle
Gilead Cystic Fibrosis Drug Gets Green Light From FDA Panel	Luke Timmerman	12/10/09	Seattle
Vertex Snags Extra $58M	Luke Timmerman	12/04/09	Boston
Vertex Raises $443M in Yet Another Monster Stock Sale	Luke Timmerman	12/03/09	Boston
Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News	Bruce V. Bigelow	08/13/09	San Diego
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey	Luke Timmerman	08/07/09	National
Cash Running Low at Altus Pharma	Ryan McBride	08/05/09	Boston
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment	Luke Timmerman	06/09/09	Boston
Alnara Pharma Completes Key Cystic Fibrosis Drug Trial, “Extremely Encouraged” by Results	Ryan McBride	05/28/09	Boston
Vertex Starts Pivotal CF Trials	Luke Timmerman	05/27/09	Boston
Obama Stimulates UW, Public Biotechs Run Low on Cash, Healionics Ships Glaucoma Product & More Seattle-Area Life Sciences News	Luke Timmerman	03/26/09	Seattle
Sticking to its Guns with Gene Therapy, Genzyme To Present Key Findings Within Days	Luke Timmerman	03/25/09	Boston
Alnara Leapfrogs Into Phase III, Just Six Months After Getting Started	Ryan McBride	03/25/09	Boston
EU Spurns Gilead’s Aztreonam	Luke Timmerman	03/20/09	Seattle
Epix Reaches Milestone in CF Research	Ryan McBride	03/11/09	Boston
Page 2 of 3	« previous page · next page »

Entry

Author

Date

Location

Gilead’s Lung Drug Ace, Bruce Montgomery, Hits Free Agent Market, Scopes Startup Ideas

Luke Timmerman

08/05/10

Seattle

Lucky 13: Xconomy Boston’s Top Stories of 2010 (So Far)

Gregory T. Huang

07/23/10

Boston